The Financialization of Disruptive Technology
The Agile Manager
SEPTEMBER 30, 2019
What if this is not a viable strategy? A recent FT Lex article on biotech investing drives the point home: "A 20-year study found only one-fifth of exits were profitable. The formula was to exploit the adaptability of software and expedite its application: get new code changes deployed every month, every day, every hour when possible.
45 
Let's personalize your content